Evidence map›Paper›PMID 41808350›Full record

ArticleImmunoHorizons2026

Fine tuning of TCR signaling via CD8αβ and PD-1 and the fate of autoreactive thymocytes during negative selection.

Martha C Zúñiga, Sangwon Hyun, Jacob Du, Shahar Dubiner, Alicia Freedman-Goretsky, Yitzhar Goretsky, Anita Pothukuchi, Nicholas A Y Fong, Alexander Berg, Caitlin Davis and 8 more

Abstract read
In one paragraph

Article in ImmunoHorizons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Martha C ZúñigaDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.ORCID 0009-0003-4834-7556
Sangwon HyunDepartment of Statistics, University of California, Santa Cruz, CA, United States.
Jacob DuDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.
Shahar DubinerDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.
Alicia Freedman-GoretskyDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.ORCID 0009-0006-9971-571X
Yitzhar GoretskyDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.
Anita PothukuchiDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.
Nicholas A Y FongDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.
Alexander BergDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.
Caitlin DavisDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.
Megumi BarataDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.
Tyler M DeveauDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.
Alisa SasDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.
Stefan AbreoDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.
Bryan KimDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.
An NguyenDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.
Jordan SchneiderDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.
Alanna WhiteDepartment of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, CA, United States.

Funding

REGULATION OF ANTIGEN PROCESSINGR01AI030554 · NIAID · UNIVERSITY OF UTAH · PI JENSEN, PETER E. · 1991 to 2009
$3.0M
NIAID NIH HHS R01 AI030554
6 · The paper itself

Abstract

During thymocyte development, positive selection produces cells whose T cell receptors (TCRs) bind to self MHC. Then, negative selection culls most thymocytes whose TCRs have too high an affinity for self MHC+peptide. Signal transduction events control these processes. CD8-αβ (via CD8-β) recruits p56lck to the immunological synapse and promotes signaling through the TCR. Conversely, PD-1 attenuates TCR signal transduction. We examined the roles of CD8-β and PD-1 in the survival of thymocytes in H-2k haplotype mice expressing a transgenic BM3 TCR, which has high affinity for the allogeneic H-2Kb MHC I molecule. In transgenic mice expressing both H-2Kb in the thymic medulla and the BM3 TCR, apoptosis eliminates most (but not all) post-selection thymocytes. To analyze the roles of CD8-β and PD-1 in the survival of post-selection thymocytes, we devised a novel probabilistic gating strategy employing Gaussian mixture models and statistical methods using sliding windows and changepoint detection. We found that at high levels of CD8-β and therefore high levels of CD8-αβ), thymocytes are prone to apoptosis, regardless of the PD-1 level. At intermediate levels of CD8-β, thymocyte survival increases concordantly with increasing PD-1 levels. At low levels of CD8-β, thymocyte survival is high regardless of the PD-1 level. Surviving DPlo post-selection thymocytes give rise to PD-1+CCR7+DN and PD-1+CCR7-DN post-selection thymocytes, which appear to become DN T cells and IELs, respectively. Thus, PD-1 appears to promote the survival of both IEL precursors and thymocytes destined for other fates. More strikingly, downregulation of CD8-β is a hallmark of autoreactive MHC I-restricted thymocytes that survive negative selection.

Indexed as

CD8 AntigensProgrammed Cell Death 1 ReceptorReceptors, Antigen, T-CellThymocytesAnimalsApoptosisMiceMice, TransgenicSignal TransductionCD8 AntigensPdcd1 protein, mouseProgrammed Cell Death 1 ReceptorReceptors, Antigen, T-CellCD8-αβnegative selectionPD-1signaling

Identifiers

PMID41808350
PMCPMC12975339

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.